MEA Surgical Sutures Market

• The growing number of surgical procedures is driving the market growth

Market CAGR for surgical sutures is driven by an increasing number of knee replacements, hip replacements, hysterectomies, bypass surgeries, and cosmetic surgeries, which are elevating the use of this device to close wounds quicker. Also, the rapidly increasing geriatric population is increasing the demand and adoption of surgical sutures due to the increasing incidence of surgical procedures such as joint replacement, angioplasty, and organ transplant among elderly patients. This is leading to higher demand for advanced devices in healthcare settings in this region.

For instance, according to a study issued by the National Centre for Biotechnology Information, it was observed that around 30.0% of aged people fall due to difficulty walking every year, leading to a rising number of patients undergoing knee replacement surgeries.

The Global Middle East and Africa Surgical Sutures Market Industry is experiencing growth driven by the rising number of surgical procedures across the region. Factors such as an aging population and the increasing prevalence of chronic diseases contribute to this trend. For instance, the demand for surgical sutures is expected to rise as more individuals undergo surgeries, including orthopedic, cardiovascular, and cosmetic procedures. In 2024, the market is projected to reach 1250 USD Million, reflecting the growing reliance on surgical interventions. This trend suggests a robust future for the industry as the number of surgical procedures continues to expand.

Major market players are investing heavily in R&D to expand their product lines, which will help the Surgical Sutures market grow even more. Market participants are also undertaking several strategic activities to enhance their footprint, with important market developments including unique product launches, contractual agreements, higher investments, mergers and acquisitions, and collaboration with other firms. To enhance and survive in a more competitive and growing market climate, the Surgical Sutures industry must deliver cost-effective items.

Manufacturing locally to minimize operational price is one of the key business tactics manufacturers in the Middle East and Africa Surgical Sutures industry use to benefit clients and enhance the market sector. The Surgical Sutures industry has offered some of the most significant medical advantages in recent years. Major players in the Surgical Sutures market, including Valneva SE, Takeda Pharmaceutical Company Limited, Abbott, AstraZeneca, Sanofi, Pfizer Inc., Janssen Global Services, LLC, and others, are attempting to enhance market demand by investing in research and development operations.

Olympus Corp is a company that produces precise machinery and instruments for optics and digital technology. The company develops, manufactures and commercializes equipment and devices for medical, imaging, healthcare, information, and other industrial markets. It delivers medical systems, including endoscopes and endoscopy, and therapy devices, products to help healthcare professionals treat patients, and scientific solutions, such as laser scanning microscopes, industrial and biological microscope systems, remote visual inspection products and non-destructive testing systems. It also delivers biomedical materials and system development services.

In October 2022, Olympus Corporation launched THUNDERBEAT Open Fine Jaw Type X surgical energy devices for open surgery in South Africa. THUNDERBEAT Open Fine Jaw Type X is a new thermal shield, a surgical energy device designed to support safer procedures.

Smith & Nephew Plc is a medical technology firm engaged in developing, manufacturing, and marketing medical devices for use in sports medicine, orthopedic reconstruction and trauma, ENT and advanced wound management. The company offers knee and hip implants to replace diseased, damaged, or worn joints; robotics-assisted technologies; and trauma-related products to stabilize fractures and deformity correction procedures. It also offers products and instruments to repair and remove soft tissue and wound care products. Smith & Nephew offers its products to surgeons; nurses and nurse specialists; physicians and general practitioners; and purchasing professionals in hospitals and healthcare insurers.

In September 2020, Smith & Nephew launched its HEALICOIL KNOTLESS Suture Anchor. With this, the company aimed to grow its revolutionary line of advanced healing solutions for rotator cuff repair.